SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-24-069550
Filing Date
2024-06-05
Accepted
2024-06-05 20:00:04
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3789
  Complete submission text file 0000950170-24-069550.txt   5236
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Issuer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O COYA THERAPEUTICS, INC. 5850 SAN FELIPE ST., SUITE 500 HOUSTON TX 77057
Business Address
Berman Howard (Reporting) CIK: 0001952986 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41583 | Film No.: 241023568